Risperidone adjunctive therapy duration in the maintenance treatment of bipolar I disorder: A post hoc analysis.

Author: BertolinSara, LamRaymond W, QianHong, ValdesMirjana, WongHubert, YathamLakshmi N

Paper Details 
Original Abstract of the Article :
Risperidone, an atypical antipsychotic medication, is recommended as a first line treatment for acute mania in patients with bipolar disorder I (BD I). It is unknown if continuing treatment with risperidone adjunct to lithium or valproate after remission of the manic episode offers additional benefi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.jad.2019.01.003

データ提供:米国国立医学図書館(NLM)

Risperidone: A Journey of Maintenance Treatment

This study explores the long-term benefits of risperidone, an atypical antipsychotic medication, for patients with bipolar disorder I (BD I). This is like navigating a long, winding desert road—the study aims to understand whether risperidone can help maintain a stable journey for patients. The study investigates whether continuing treatment with risperidone after remission of manic episodes can help prevent relapses.

Risperidone: A Potential Oasis in the Desert of Bipolar Disorder

The study is looking for answers to an important question: can risperidone act as a stabilizing force for patients with BD I, preventing them from falling back into a state of mania? This is like searching for a hidden oasis in the desert—a place that provides a safe haven and a sense of stability.

Bipolar Disorder: A Long and Winding Road

Bipolar disorder is a complex and challenging condition that can significantly impact a person's life. This research seeks to improve the long-term treatment of BD I, making the journey through this desert a little bit smoother. This is like providing a compass and a map to navigate the challenging landscape of bipolar disorder.

Dr.Camel's Conclusion

This study explores the potential benefits of risperidone as a long-term treatment for BD I. It's like a camel caravan crossing a vast desert—the study aims to find ways to maintain a stable and safe journey for patients with BD I.

Date :
  1. Date Completed 2019-04-19
  2. Date Revised 2019-04-19
Further Info :

Pubmed ID

30795492

DOI: Digital Object Identifier

10.1016/j.jad.2019.01.003

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.